C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 401/00 (2006.01) A61K 31/593 (2006.01) A61P 3/14 (2006.01)
Patent
CA 2463505
The present invention provides novel 16-ene-C25-oxime and 16-ene-C-25-oxime ether analogs of 1.alpha.,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24. In particular, the compound of Formula I are useful for treating diseases which benefit from a modulation of the levels of 1.alpha.,25-dihydroxy vitamin D3, for example, cell-proliferative disorders.
La présente invention concerne des nouveaux analogues éther 16-ene-C25-oxime et 16-ene-C-25-oxime de 1.alpha.,25-dihydroxy vitamine D¿3?, des compositions comprenant ces composés et des méthodes permettant d'utiliser ces composés en tant qu'inhibiteurs de CYP24. En particulier, le composé représenté par la formule I est utilisé pour traiter des maladies bénéficiant d'une modulation des niveaux de 1.alpha.,25-dihydroxy vitamine D¿3?, par exemple, des troubles de prolifération cellulaire.
Halford Bethany
Jeon Heung Bae
Jones Glenville
Kahraman Mehmet
Posner Gary H.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Cytochroma Inc.
Johns Hopkins University
LandOfFree
Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1850611